Latest linezolid Stories
Targanta Therapeutics Corporation (Nasdaq: TARG) announced today that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee will review the Company's New Drug Application (NDA) for oritavancin on November 19, 2008.
BOSTON, Oct. 14 /PRNewswire/ -- Paratek Pharmaceuticals, Inc.
By Maranich, Ashley M Rajnik, Michael ABSTRACT Although vancomycin-resistant Enterococcus infection of the central nervous system is not common, this organism is becoming an increasing problem in nosocomial infections.
Arpida, a biopharmaceutical company, has completed enrollment in the Phase II 'intravenous-to-oral' switch trial with oral iclaprim in patients with complicated skin and skin structure infections. The trial was designed as a multi-centre, double-blind comparative study.
Trius Therapeutics has initiated a Phase II testing of the oral form of its second-generation oxazolidinone antibacterial drug TR-701.
MALVERN, Penn. and WALTHAM, Mass., Sept.
SAN DIEGO, Sept. 22 /PRNewswire/ -- Trius Therapeutics, Inc. today announced the initiation of Phase 2 testing of the oral form of its second-generation oxazolidinone antibacterial drug TR-701.
Enanta Pharmaceuticals, a developer of small molecule anti-infective drugs, has initiated a Phase Ia study on investigational oral antibiotic EDP-322, a methicillin-resistant Staphylococcus aureus-active Bicyclolide, a novel macrolide-related drug class with a distinct resistance profile.
WATERTOWN, Mass., Sept.
The death rate for infective endocarditis -- an infection where bacteria destroy the heart -- has increased, a British cardiologist warns. Despite medical improvements, the rate for infective endocarditis has been virtually unchanged for last 20 years, and now seems to be rising again, Dr.
Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...
Enterococcus faecalis "“ formerly classified as part of the Group D Streptococcus system "“ is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is one of the main constituents of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of the cases. It is a non-motile, facultatively anaerobic...
- A gift; a largess; a gratuity; a present; a dole.